Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2020-03-21 (6 years)Status: ActiveBusiness sector: Activités des sociétés holdingLocation: KINGERSHEIM (68260), Haut-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SPFPL ELSASS & LYS PHARMA is a French company
founded 6 years ago,
specialized in the sector Activités des sociétés holding.
Based in KINGERSHEIM (68260),
this company of category PME
has financial data available below.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SPFPL ELSASS & LYS PHARMA (SIREN 881683361)
Indicator
2021
Revenue
N/C
Net income
0 €
EBITDA
N/C
Net margin
N/C
Revenue and income statement
In 2021, SPFPL ELSASS & LYS PHARMA records a net loss of 0 €. This deficit will reduce equity on the balance sheet.
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 18040%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 99%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
18039.877%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
Debt ratio
18039.877
Financial autonomy
99.449
Repayment capacity
None
Cash flow / Revenue
None%
Sector positioning
Debt ratio
18039.882021
2021
Q1: 0.13
Med: 15.19
Q3: 84.93
Average
In 2021, the debt ratio of SPFPL ELSASS & LYS PHARMA (18039.88) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
99.45%2021
2021
Q1: 21.52%
Med: 60.87%
Q3: 89.3%
Excellent
In 2021, the financial autonomy of SPFPL ELSASS & LYS PHARMA (99.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 21.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
Liquidity ratio
21.682
Interest coverage
None
Sector positioning
Liquidity ratio
21.682021
2021
Q1: 108.17
Med: 446.13
Q3: 2343.75
Watch
In 2021, the liquidity ratio of SPFPL ELSASS & LYS PHARMA (21.68) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SPFPL ELSASS & LYS PHARMA in its sector
Comparison with sector Activités des sociétés holding
Similar companies (Activités des sociétés holding)
Compare SPFPL ELSASS & LYS PHARMA with other companies in the same sector:
Frequently asked questions about SPFPL ELSASS & LYS PHARMA
What is the revenue of SPFPL ELSASS & LYS PHARMA ?
The revenue of SPFPL ELSASS & LYS PHARMA is not publicly disclosed (confidential accounts filed with INPI).
Is SPFPL ELSASS & LYS PHARMA profitable?
Profitability information is not publicly available.
Where is the headquarters of SPFPL ELSASS & LYS PHARMA ?
The headquarters of SPFPL ELSASS & LYS PHARMA is located in KINGERSHEIM (68260), in the department Haut-Rhin.
Where to find the tax return of SPFPL ELSASS & LYS PHARMA ?
The tax return of SPFPL ELSASS & LYS PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SPFPL ELSASS & LYS PHARMA operate?
SPFPL ELSASS & LYS PHARMA operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart